Diabetes PubMed

  • Increase font size
  • Default font size
  • Decrease font size
Home Signs and Symptoms Diagnosis Functional integrity of neural retina in 2. type diabetics

Functional integrity of neural retina in 2. type diabetics

Cesk Slov Oftalmol. 2009 Jul;65(4):124-30.

[Article in Slovak]

Beszédesová N, Budinská E, Skorkovská S.

Klinika nemocí ocních a optometrie, LF MU a FN u sv. Anny, Brno. This e-mail address is being protected from spambots. You need JavaScript enabled to view it

The purpose of this prospective longitudinal study was to investigate early defects in functional integrity of neural retina in 2. type diabetic patients without or with mild diabetic retinopathy (DR) since there is an evidence of early functional changes in neural retina before occurrence of clinical manifestation of DR. Psychophysical test of contrast sensitivity (CS) was used for the detection of these changes. Relation between CS and systemic risk factors (HbAlc, blood pressure (BP), serum lipids and BMI) were also evaluated during a follow-up time. There were 48 recent diabetics without DR included in this study that were examined 3 times and compared to 23 diabetics with mild DR. The CS tests were performed using both Sine Wave Contrast Test (SWCT) and Pelli-Robson (PR) test. The reference values for CS threshold were derived from a CS of a control group of 52 healthy individuals. Abnormal CS ascertained by both methods, SWCT and PR, was observed in diabetics with mild NPDR. In comparison to the control group, there was a statistically significant difference of CS in spatial frequencies (SF) of 1.5, 6, 12, 18 cycles per degree (cy/deg). In comparison to diabetics without DR there was a significant difference of CS in SF of 6, 12 and 18 cy/deg in diabetics with mild NPDR. Abnormal CS was noticed in 47.8% (SWCT) or 21.7% (PR) of diabetics with DR. Statistically significant influence of high systolic BP on CS values and visual acuity was noticed. There were no abnormalities in CS in patients without DR comparing to control group during the whole follow-up. However, there was an improvement of CS in SF of 18 cy/deg observed between 1. and 3. evaluation of CS. Interaction of change in values of HbAlc and total cholesterol to HDL ratio had significant influence on CS improvement. Diabetics without DR had significantly better diabetes and blood pressure control in comparison to the diabetics with DR. In conclusion, it was not proved in this study that CS test is suitable for the screening for DR or early functional defects in neural retina before clinical manifestation of DR. Early diagnosis of DM and good compensation of diabetes, blood pressure and serum lipids level can postpone the onset of DR as well as the visual functions impairments.

PMID: 19750829

 

Bookmark and Share

Popular Diabetes PubMed Citations

Newsflash

Millions unite for diabetes awareness on World Diabetes Day 2010
Starting today, people from all corners of the world are uniting together for three days of celebration to put diabetes firmly in the public spotlight. World Diabetes Day is the best opportunity there is to draw attention to the silent killer that is diabetes.
 
Bristol-Myers Squibb Foundation Launches $100 Million Initiative
The Bristol-Myers Squibb Foundation announced Together on Diabetes®: Communities Uniting to Meet America's Diabetes Challenge, a 5-year, $100 million initiative to help patients living with type 2 diabetes better manage their disease beyond the doors of their doctor's office - in their homes and communities - and for the course of their disease.
 
New global survey reveals more than one in three patients fail to take insulin as prescribed
More than one in three diabetes patients skip doses or fail to take their insulin as prescribed, stating that they have done so on average three times in the last month, and 77% of physicians estimate that in reality this number could be as high as six doses*, according to the Global Attitudes of Patients and Physicians in Insulin Therapy (GAPPTM) survey, released today by Novo Nordisk.
 

Facebook Page Twitter Subscribe to Latest Diabetes PubMed facts... by Email RSS

Subscribe

Get Diabetes PubMed facts delivered by email. Enter your email address:


Delivered by FeedBurner

Who's Online

We have 4 guests online

Sponsored Links

PharmaNews.eu
PharmaNews.eu - the dynamic European pharmaceutical news engine.
www.pharmanews.eu

Advertise here